Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
Sagara, Issaka, Beavogui, Abdoul Habib, Zongo, Issaka, Soulama, Issiaka, Borghini-Fuhrer, Isabelle, Fofana, Bakary, Traore, Aliou, Diallo, Nouhoum, Diakite, Hamadoun, Togo, Amadou H, Koumare, Sekou, KLanguage:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(18)30291-5
Date:
March, 2018
File:
PDF, 555 KB
english, 2018